Early proteomics of ovary cancer: myth or reality?

   
Makarov O.V.1, Govorun V.M.2, Taranets I.N.1, Goufman E.I.2, Gritsai A.N.3, Archakov A.I.2

1. Russian State Medical University, Moscow
2. Institute of Biomedical Chemistry Russian Academy of Medical Sciences
3. Russian Research Centre for Oncology Russian Academy of Medical Sciences
Section: Experimental/Clinical Study
PubMed Id: 14569865
Year: 2003  Volume: 49  Issue: 1  Pages: 2-7
Literature data summarizing new approaches and importance of early ovary cancer diagnostics have been reviewed. Alpha-feta-protein (AFP) and SA125 were the most reliable markers for determination of early ovary cancer stages. Nevertheless, these markers don't reflect the disease stage, malignance and they don't possess sufficient specificity. New methodical approaches have recently been introduced. They include combination of 2-D electrophoresis with mass-spectrometry. These methods allow to inventory and identify almost all proteins of various tissues. Using these methods for scanning proteins from biopsies of ovary cancer tissues new markers have been discovered.
Download PDF:
Citation:

Makarov, O. V., Govorun, V. M., Taranets, I. N., Goufman, E. I., Gritsai, A. N., Archakov, A. I. (2003). Early proteomics of ovary cancer: myth or reality?. Biomeditsinskaya khimiya, 49(1), 2-7.
References  
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)